Exercise dose, intensity don't impact reduction in liver fat

Exercise dose, intensity don't impact reduction in liver fat

(HealthDay)—Reductions in liver fat or visceral adipose tissue (VAT) do not differ significantly with the dose or intensity of aerobic exercise, according to a study published online April 8 in the Journal of Hepatology.

Shelley E. Keating, from the University of Sydney, and colleagues examined the efficacy of commonly prescribed exercise doses for reducing and VAT. Forty-seven inactive and overweight/obese adults were randomized to receive eight weeks of low- to moderate-intensity, high-volume aerobic exercise (LO:HI); high-intensity, low-volume aerobic exercise (HI:LO); low- to moderate-intensity, low-volume aerobic exercise (LO:LO); or placebo.

The researchers observed a significant change in group × time interaction in liver fat, with reductions of 2.38 percent in HI:LO, 2.62 percent in LO:HI, and 0.84 percent in LO:LO and an increase of 1.1 percent in placebo. There were significant reductions in VAT in the HI:LO, LO:HI, and LO:LO groups but not in placebo. No significant differences were seen between the dose or intensity of the and the deceases in liver fat or VAT.

"All of the regimens employed reduced liver fat and VAT by a small amount without clinically significant weight loss," the authors write.

Two authors disclosed financial ties to the pharmaceutical industry.

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2015 HealthDay. All rights reserved.

Citation: Exercise dose, intensity don't impact reduction in liver fat (2015, April 10) retrieved 25 June 2024 from https://medicalxpress.com/news/2015-04-dose-intensity-dont-impact-reduction.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

New study indicates that exercise improves non-alcoholic fatty liver disease

28 shares

Feedback to editors